featured
Intravitreous Aflibercept for the Prevention of Vision-Threatening Complications of Diabetic Retinopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
JAMA 2023 Feb 07;329(5)376-385, RK Maturi, AR Glassman, K Josic, CW Baker, AT Gerstenblith, LM Jampol, A Meleth, DF Martin, M Melia, OS Punjabi, S Rofagha, H Salehi-Had, CR Stockdale, JK SunFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.